Transaction

Search documents
Zscaler Announces Proposed Offering of $1.5 Billion of Convertible Senior Notes Due 2028
Globenewswire· 2025-06-30 10:58
Core Viewpoint - Zscaler, Inc. plans to offer $1.5 billion in convertible senior notes due 2028, with an option for initial purchasers to buy an additional $225 million, subject to market conditions [1][2]. Group 1: Offering Details - The notes will be senior unsecured obligations, maturing on July 15, 2028, and will accrue interest payable semiannually [2]. - The notes can be converted into cash, shares of Zscaler's common stock, or a combination of both at the company's discretion [2]. - The specific terms, including interest rate and conversion rate, will be determined at the time of pricing [2]. Group 2: Use of Proceeds - A portion of the net proceeds will be used to cover costs associated with capped call transactions, while the remainder will be allocated for general corporate purposes, including working capital and potential acquisitions [3]. Group 3: Capped Call Transactions - Zscaler expects to enter into capped call transactions to mitigate potential dilution of its common stock upon conversion of the notes [4]. - These transactions will cover the number of shares underlying the notes and are subject to anti-dilution adjustments [4]. - If the initial purchasers exercise their option for additional notes, Zscaler will enter into further capped call transactions [4]. Group 4: Market Impact - The option counterparties may engage in purchasing Zscaler's common stock or derivatives, which could influence the market price of the stock and the notes [5][6]. - This activity may affect the conversion ability of noteholders and the value of shares received upon conversion [6]. Group 5: Regulatory Compliance - The notes will be offered to qualified institutional buyers under Rule 144A of the Securities Act, and neither the notes nor the shares have been registered under the Securities Act [7].
Why Merchants Prefer Stablecoins Over Traditional Payments
Digital Asset News· 2025-06-30 06:27
But also there's this thing called chargebacks. Merchants like stable coins. They merchants like stable coins.The lower transaction cost because it's, you know, it's nothing. It's not 3%, 1%, 0 point. It's really super low.And this is why this is why Visa is tracking it. They're tracking all these transaction because they don't want to become obsolete. But they say tra chargebacks are also a problem.You know, people go on there like I want this and that. Ah, I don't want that. And then they have to charge a ...
X @mert | helius.dev
mert | helius.dev· 2025-06-29 22:08
Solana reaching ATHs in successful transactionsand this is before blockspace doublingfaster https://t.co/OsEeIECJq6 ...
X @Token Terminal 📊
Token Terminal 📊· 2025-06-29 18:42
RT Token Terminal 📊 (@tokenterminal)💵🌱 @multicoincap invested in Jito's $10m Series A in 2022.Three years later, ~50% of all transaction fee spend on @solana runs via @jito_sol. https://t.co/Ew89124TLY ...
X @Token Terminal 📊
Token Terminal 📊· 2025-06-29 16:40
💵🌱 @multicoincap invested in Jito's $10m Series A in 2022.Three years later, ~50% of all transaction fee spend on @solana runs via @jito_sol. https://t.co/Ew89124TLY ...
DGL Investments No. 1 Inc. Announces Termination of Letter of Intent With Rep Group Limited and Perspectives Productions Limited
Globenewswire· 2025-06-27 15:13
Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, June 27, 2025 (GLOBE NEWSWIRE) -- DGL Investments No. 1 Inc. ("DGL" or the “Company”) (TSXV: DGL.P) announces that the Letter of Intent it had entered into with Rep Group Limited (“REP”) and Perspectives Productions Limited (“Perspectives” and collectively with REP, the “Targets”) as announced by News Release dated April 14, 2025 has been mutually terminated by the parties as of June 26, 20 ...
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
Globenewswire· 2025-06-27 11:00
—Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future milestones— —BioCryst plans to use proceeds to retire all remaining term debt, which will eliminate approximately $70 million of future interest payments over remaining life of the loan— —With this transaction, BioCryst expects to end 2027 with approximately $700 million in cash and no term debt (an increase of $400 million from prior 2027 net cash guidance)— RES ...
X @BREAD | ∑:
BREAD | ∑:· 2025-06-26 14:02
You're not bullish enough on this industry and the capacity required to meet global demand.HyperCORE is doing a ~10k TPS with ~5% CEX volume numbers and no tradfi assets.MegaETH is targeting 100k TPS because it will be needed. IBRL is a mindset.https://t.co/6oxGvLGTut ...
X @mert | helius.dev
mert | helius.dev· 2025-06-26 13:38
if toly is such a good guy then why dont my txns land sometimes ...
Unisys Announces Early Results of Previously Announced Cash Tender Offer
Prnewswire· 2025-06-26 13:00
BLUE BELL, Pa., June 26, 2025 /PRNewswire/ -- Unisys Corporation (NYSE: UIS) ("we," "us," "our," "Unisys" or the "Company") is releasing early results as of 5:00 p.m., New York City time, on June 25, 2025 (the "Early Tender Expiration"), of our previously announced (i) tender offer (the "Tender Offer") to purchase for cash any and all of our outstanding 6.875% Senior Secured Notes due 2027 (the "Notes") and (ii) solicitation of consents from holders (each, a "Holder" and, collectively, the "Holders") of the ...